Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant Pharmaceuticals
Go back to Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant Pharmaceuticals| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||
| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||

